Quality of life (QOL) differentiation analysis in patients undergoing controlled ovarian stimulation (COS) with two different preparations of recombinant human follicle-stimulating hormone (r-hFSH) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Beresniak, A
  • Brasseur, P
  • Daya, Salim
  • Silverberg, K
  • Wikland, M
  • Duru, G
  • Decostered, G
  • Brasseur, P
  • Blatz, S

publication date

  • November 1, 2003